Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AdaptHealthAHCO -2.92%64 FCF Margin % is -2.83% as of Jun. 2026. GuruFocus rates AHCO with a GF Score™ of 64/100 and a GF Value™ of $10.50 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 812 Medical Devices & Instruments companies, AdaptHealth ranks better than 57.64% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. AdaptHealth's Free Cash Flow for the
three
months ended in Jun. 2026 was $-21 Mil. AdaptHealth's Revenue for the
three
months ended in Jun. 2026 was $740 Mil. Therefore, AdaptHealth's FCF Margin % for the quarter that ended in Jun. 2026 was -2.83%.
The historical data trend for AdaptHealth's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, AdaptHealth's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AdaptHealth FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AdaptHealth's FCF Margin % distribution charts can be found below:
* The bar in red indicates where AdaptHealth's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AdaptHealth (AHCO) has a FCF Margin % of -2.83% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on AdaptHealth and its competitors. According to the industry distribution chart, AdaptHealth ranks #344 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 42.4%.
Is AdaptHealth's FCF Margin % too high?
AdaptHealth's current FCF Margin % is -2.83%. Based on the distribution chart, AdaptHealth ranks #344 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, AdaptHealth has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AdaptHealth's FCF Margin % compare to INSP and IART?
According to the Medical Devices & Instruments industry distribution chart, AdaptHealth ranks #344 out of 812 companies for FCF Margin %. This puts AdaptHealth in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on AdaptHealth and its competitors. AdaptHealth's current FCF Margin % is -2.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AdaptHealth stock overvalued right now?
Based on GuruFocus' analysis, AdaptHealth (AHCO) is currently considered Possible Value Trap. The stock's GF Value™ is $10.50, compared to a current price of $5.66 — trading 46.1% below its estimated fair value. The current FCF Margin % is -2.83%. AdaptHealth's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For AdaptHealth (AHCO), the current FCF Margin % is -2.83% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AdaptHealth (AHCO) Overvalued in 2026?
Based on GuruFocus' analysis, AdaptHealth stock appears to be undervalued.
The current stock price of $5.66 is trading 46.1% below its estimated GF Value™ of $10.50.
GuruFocus considers AdaptHealth to be Possible Value Trap.
Key valuation signals for AHCO:
FCF Margin %: -2.83%
GF Value™: $10.50 vs. price of $5.66 (46.1% below fair value)
No single metric tells the full story. See the AHCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
64GF Score
Get the complete analysis for AHCO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AHCO has been successfully added to your 
